Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13,838,977
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
5,810,614
-
Shares change
-
-48,275
-
Total reported value, excl. options
-
$37,033,240
-
Value change
-
-$275,967
-
Put/Call ratio
-
9.77%
-
Number of buys
-
9
-
Number of sells
-
-10
-
Price
-
$6.38
Significant Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q2 2023
34 filings reported holding CSBR - CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share as of Q2 2023.
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,810,614 shares
of 13,838,977 outstanding shares and own 41.99% of the company stock.
Largest 10 shareholders include BATTERY MANAGEMENT CORP. (2,421,673 shares), NEA Management Company, LLC (1,713,720 shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (665,428 shares), RENAISSANCE TECHNOLOGIES LLC (124,891 shares), BlackRock Inc. (117,139 shares), ESSEX INVESTMENT MANAGEMENT CO LLC (111,340 shares), DIMENSIONAL FUND ADVISORS LP (87,671 shares), AMERIPRISE FINANCIAL INC (84,831 shares), VANGUARD GROUP INC (68,007 shares), and GEODE CAPITAL MANAGEMENT, LLC (58,916 shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.